Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Accounts-Payable" stands at 2.82 Billion Hong Kong Dollars as of 06/30/2025, the highest value since 09/30/2022.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Accounts Payable" stands at 2.82 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 38.26 percent compared to the value the year prior.
The 1 year change in percent is 38.26.
The 3 year change in percent is -8.32.
The 5 year change in percent is 0.6683.
The 10 year change in percent is 146.09.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accounts Payable | 905,699,262,464.00 |
![]() | Johnson & Johnson - Accounts Payable | 486,508,953,600.00 |
![]() | AbbVie Inc - Accounts Payable | 399,570,305,024.00 |
![]() | Roche Holding AG - Accounts Payable | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Accounts Payable | 280,205,508,085.11 |